HPGDS and cystic fibrosis-related liver disease: Several studies have suggested the use of serum markers of hepatic fibrogenesis for early detection of CFLD, such as collagen type IV (CL-IV), tissue inhibitor of metalloproteinase (TIMP-1), prolyl hydroxylase (hPH) and glutathione S-transferase(22, 61).